IVERIC bio
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $189,906,000.

Profit Margin

IVERIC bio, Inc. (NASDAQ:ISEE): Profit margin
2013 0 -51.14M
2014 41.25M -98.18M -237.98%
2015 51.50M -105.71M -205.26%
2016 50.90M -193.42M -379.93%
2017 209.97M 114.20M 54.39%
2018 0 63.08M
2019 0 -58.85M
2020 0 -84.54M
2021 0 -114.23M
2022 0 -175.74M

ISEE Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
00000209.97M50.90M51.50M41.25M0
Cost of revenue
0000000000
Gross profit
00000209.97M50.90M51.50M41.25M0
Operating exp.
Research and development
117.01M85.06M62.78M39.64M41.73M66.28M196.29M131.01M88.38M33.21M
Selling and marketing
0000000000
Total operating expenses
189.90M114.75M88.73M61.27M65.34M101.97M246.47M175.03M121.77M47.42M
Operating income
-189.90M-114.75M-88.73M-61.27M-65.34M108.00M-195.56M-123.52M-80.51M-47.42M
Other income (expenses), net
4.69M235K494K2.30M127.37M1.48M1.73M1.02M217K-3.72M
Income before tax
-185.21M-114.52M-88.24M-58.97M62.02M109.49M-193.82M-122.50M-80.29M-51.14M
Income tax expense
-9.46M-284K-3.69M-111K-1.06M-4.71M-406K-16.78M17.89M-2.26M
Net income
-175.74M-114.23M-84.54M-58.85M63.08M114.20M-193.42M-105.71M-98.18M-51.14M
Earnings per share
Basic EPS
-1.45-1.12-1.14-1.391.73.18-5.45-3.06-2.95-5.68
Diluted EPS
-1.45-1.12-1.14-1.391.73.17-5.45-3.06-2.95-5.68
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source